The immediate goal of this research proposal is to investigate critically the side chain metabolism of both 1, 25- dihydroxyvitamin D3 (1, 25 (OH)2D3) and 25-hydroxyvitamin D3 (25-OH-D3) in the rat with a long term goal to understand the physiological significance of side chain metabolism of vitamin D in general. The factors, regulating the production of 1,25 (OH)2D3 in the kidney have been well studied. However, as the circulating as well as the tissue levels of 1, 25(OH)2D3 depend not only on its production but also on its further metabolism, it is vital to understand thoroughly the target tissue metabolism of 1, 25 (OH)2D3 before we embark on investigating the various factors that regulate the target tissue metabolism of 1, 25 (OH)2D3. In vitamin D intoxication, the serum level of 25(OH)D3 can be very high and it appears the toxic effects of vitamin D3 in hypervitaminosis D can be due to high circulating levels of 25(OH)D3. Therefore, understanding of the inactivation pathways of 25(OH)D3 becomes important especially in hypervitaminosis D. Thus, the proposed studies designed to understand the side chain metabolism of both 1,25(OH)2D3 and 25(OH)D3 using the techniques of the isolated perfused rat kidney and liver systems should fill some of the gaps that still exist in our present understanding of the further metabolism of both 1,25(OH)2D3 and 25(OH)D3. This information may also influence our future research into the understanding of the pathogenesis of some of the disease states where there is disturbed vitamin D metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DK039138-05
Application #
3463030
Study Section
General Medicine B Study Section (GMB)
Project Start
1988-05-01
Project End
1993-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Women and Infants Hospital-Rhode Island
Department
Type
DUNS #
069851913
City
Providence
State
RI
Country
United States
Zip Code
02905
Lee, N E; Reddy, G S; Brown, A J et al. (1997) Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3. Biochemistry 36:9429-37
Siu-Caldera, M L; Clark, J W; Santos-Moore, A et al. (1996) 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. J Steroid Biochem Mol Biol 59:405-12
Partyka, C M; Gelardi, N L; Fadden, K et al. (1995) Lack of production and growth-modulating effects of 1a,25-dihydroxyvitamin D3 in cultured fetal rat hepatocytes. Biol Neonate 67:194-202
Siu-Caldera, M L; Zou, L; Ehrlich, M G et al. (1995) Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones. Endocrinology 136:4195-203
Yeung, B; Vouros, P; Siu-Caldera, M L et al. (1995) Characterization of the metabolic pathway of 1,25-dihydroxy-16-ene vitamin D3 in rat kidney by on-line high performance liquid chromatography-electrospray tandem mass spectrometry. Biochem Pharmacol 49:1099-710
Lemire, J M; Archer, D C; Reddy, G S (1994) 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818-21
Yeung, B; Vouros, P; Reddy, G S (1993) Characterization of vitamin D3 metabolites using continuous-flow fast atom bombardment tandem mass spectrometry and high-performance liquid chromatography. J Chromatogr 645:115-23
Rubin, L P; Yeung, B; Vouros, P et al. (1993) Evidence for human placental synthesis of 24,25-dihydroxyvitamin D3 and 23,25-dihydroxyvitamin D3. Pediatr Res 34:98-104
Reddy, G S; Tserng, K Y (1989) Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 28:1763-9